Board of Directors

Chris Cardon, Chief Executive Officer

Length of service

Appointed to the Board on Admission

Committee membership

By invitation

Key skills and experience

Chris founded Ecuphar as Chris Cardon NV in 2001 to capitalise on opportunities identified in the animal health industry. The company began with the development of a number of original and high-quality OTC products for companion animal markets. Chris graduated as a pharmacist from the University of Ghent in 1993 after which he took over his family's pharmacy business. In 1995, he completed an MBA at the Vlerick Leuven-Gent Management School and then in 2006 received the prestigious award "Export Lion of Flanders 2005" in the Young Exporters category.

Chris has a strong entrepreneurial background in human OTC product development. In 1996, Chris established Mooss Pharma, a company which developed human OTC products that were exclusively distributed by pharmacists. Mooss Pharma developed into a key player in the Belgian market, and in 2001 the OTC assets of Mooss Pharma were acquired by Omega Pharma.

Chris Cardon

Iain Menneer, Chief Operating Officer

Length of service

Appointed to the Board in 2011

Committee membership

By invitation

Key skills and experience

Following Admission, Iain will fulfil the role of Chief Operating Officer of the Group.

Following roles in the brewery industry in product development and technical research, Iain joined the Group in 2003, working in sales, marketing and business development roles, including an instrumental role in the new product development pipeline.

Iain was promoted to the Board as Director of Marketing in July 2011. Iain was appointed Managing Director of Animalcare Limited in March 2012 and subsequently Chief Executive Officer of the Company in January 2013, since when he has led the transformation of the business infrastructure, including the focus on new product development.

Iain has a degree and PhD in Chemistry, both from Newcastle University.

Iain Menneer

Walter Beyers, Chief Financial Officer

Length of service

Appointed to the Board on Admission

Committee membership

By invitation

Key skills and experience

Walter has significant experience in senior financial management positions in publicly listed and privately owned companies.

Walter started his career with the American multinational Cargill and subsequently joined his family's business in logistics until he sold that business. He then became Finance director of Akeda, a Belgian family office and in 1998 he joined Euronext-listed company USG People, for which he worked for eight years, before working for listed companies Autogrill and Ecodis, then returning to USG People in 2009 for a further five years as VP Finance, being responsible for ten countries in Europe.

Before joining Ecuphar as CFO in April 2016, he was CFO Europe for the US based FCMG manufacturer Ecover-Method.

Walter has a master's degree in Economics from the University of Antwerp and obtained an MBA from the University of Leuven (KUL) in Belgium.

Walter Beyers

Jan Boone, Non-Executive Chairman

Length of service

Appointed to the Board on Admission

Committee membership

Audit Committee, Nomination Committee and Remuneration Committee

Key skills and experience

Jan is the Chief Executive Officer of Lotus Bakeries, which is listed on Euronext Brussels. He started at Lotus Bakeries as managing director in 2005 and was named chief executive officer in 2011.

Between 2000 and 2005, Jan served as Head of Corporate Controlling and Member of the Executive Committee of Omega Pharma NV. He started his career in the audit department at PricewaterhouseCoopers and holds a Master's degree in Applied Economics (KU Leuven) and a Master's degree in Audit (UMH).

In addition to his role at Lotus Bakeries, Jan serves as non-executive director of Club Brugge.

Jan Boone

Edwin Torr, Senior Independent Non-Executive Director

Length of service

Appointed to the Board on Admission 

Committee membership

Audit Committee, Nomination Committee and Remuneration Committee

Key skills and experience

Edwin Torr has significant experience of international veterinary and animal health markets, gained over a period of more than 20 years, during which time he has worked for ICI, Pitman Moore, Alfa Laval Agri and Dechra Pharmaceuticals. He was part of the management buyout team that set up Dechra Veterinary Products in 1997, and was an executive director on the board of the Dechra entity that was listed on the London Stock Exchange from 2000 until 2013. During this time, he was responsible for business development, managed the European business unit and was instrumental in setting up the USA business. Since 2014, Edwin has independently advised various companies on sales and marketing structures, M&A opportunities, 'in' and 'out' licensing of products and investment opportunities within the veterinary and animal health market sector.

Edwin Torr

James Lambert MBE, Non-Executive Director

Length of service

Appointed to the Board in 2008

Committee membership

Chairman of the Nomination Committee

Key skills and experience

James was appointed Chairman of the Group in 2008 when the Company was acquired by Ritchey plc for whom he had been the chairman since 2005 and a non-executive director since 2003. James was previously co-founder and Chief Executive Officer of R&R Ice Cream where under James' leadership, R&R Ice Cream made a series of acquisitions to become the largest ice cream manufacturer by volume in the UK. James is now chairman of Burton's Biscuits, a company he helped Ontario Teachers' Pension Plan acquire in 2013. He was also awarded the EY UK Entrepreneur of the Year award in 2014.

James Lambert

Marc Coucke, Non-Executive Director

Length of service

Appointed to the Board on Admission

Committee membership

Chairman of the Remuneration Committee

Key skills and experience

Marc founded Omega Pharma in 1987 and developed the company into a leading pan-European OTC health and personal care business. Marc has served as both chairman and chief executive officer of Omega Pharma. Following the sale thereof in 2015 to Perrigo Company plc for €3.6 billion, Marc invests via his private investment firm Alychlo NV in several listed and non-listed companies.

Marc currently serves as chairman of Mithra Pharmaceuticals (EBR: MITRA) and as non-executive director of Fagron (EBR: FAGR), in addition to a number of private companies.

Marc graduated as a pharmacist from the University of Ghent after which he completed an MBA at the Vlerick Leuven-Gent Management School. He was also awarded, as Chief Executive Officer of Omega Pharma, the EY Flemish Entrepreneur of the Year award in 2002.

Marc Coucke

Lord Nick Downshire, Non-Executive Director

Length of service

Appointed to the Board in 2008

Committee membership

Chairman of the Audit Committee

Key skills and experience

Nick joined the Board of the Group when it was acquired by Ritchey plc for whom he had acted as a director since 1998. Nick is a qualified chartered accountant who has worked in corporate finance and venture capital. He has held and still holds non-executive directorships in a diverse range of businesses in the insurance, agricultural, hospitality, education and technology sectors. Nick runs an estate in Yorkshire with a range of activities including quarrying, renewables, forestry and a hotel as well as agriculture and real estate. He is also Chairman of the National Agriculture and Land Use committee for the Country Landowners & Business Association for Yorkshire and sits on their national policy committee, as well as acting as a trustee for a number of charitable and land related trusts.

Lord Downshire